HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conservative treatment of phimosis with fluticasone proprionate 0.05%: a clinical study in 1185 boys.

AbstractOBJECTIVE:
Circumcision has been the traditional method of choice in the treatment of boys with phimosis. Recently, several published studies worldwide have focused their interest on more conservative approaches in management of this condition. These studies advocate the use of topical steroids in the phimotic foreskin. We aimed to investigate the efficacy and safety of a medium potency corticosteroid in boys with different types of prepuce retractabilty.
PATIENTS AND METHODS:
A prospective study was performed involving boys referred to our hospital for possible phimosis between January 2004 and February 2008. All were treated initially with fluticasone proprionate 0.05% for a period of 4-8 weeks. Patients were reassessed after 6 months of follow up.
RESULTS:
A total of 1185 boys with a diagnosis of phimosis were treated with fluticasone proprionate 0.05%. Successful results were achieved in 1079 (91.1%) patients including boys with mild balanitis xerotica obliterans. No side effects were noticed.
CONCLUSION:
Our results show that fluticasone proprionate 0.05%, a mild potent corticosteroid, is effective and safe in the treatment of boys with different types of phimosis.
AuthorsNick Zavras, Efstratios Christianakis, Demetrios Mpourikas, Khalil Ereikat
JournalJournal of pediatric urology (J Pediatr Urol) Vol. 5 Issue 3 Pg. 181-5 (Jun 2009) ISSN: 1873-4898 [Electronic] England
PMID19097823 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Androstadienes
  • Dermatologic Agents
  • Fluticasone
Topics
  • Administration, Topical
  • Adolescent
  • Androstadienes (administration & dosage)
  • Balanitis Xerotica Obliterans (drug therapy, pathology)
  • Child
  • Child, Preschool
  • Dermatologic Agents (administration & dosage)
  • Fluticasone
  • Follow-Up Studies
  • Foreskin (drug effects, pathology)
  • Humans
  • Male
  • Phimosis (drug therapy, pathology)
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: